chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Red blood cells urine positive, SARS-CoV-2 test positive, Speech disorder, Urinary sediment present, Urine analysis
Clinical narrative: 1/8/2022- Chief Complaint: Lethargy- Source of Information: Available medical record. History of Present Illness:  This is a 69 y.o. female with PMH of being a conjoined twin, developmental delay, GERD, hyperlipidemia, hypertension, seizure disorder, and hypothyroidism presents to the emergency department chief complaint of lethargy and altered mental status. The patient has none nonverbal at baseline with occasional "yes "or "no". History is provided by the patient's first cousin who was the patient's guardian. Guardian states that the patient has had poor p.o. intake over the last 6 days. She states that typically the patient is able to ambulate on her own with a walker but has not done so over the past 6 days. She states that she is fully vaccinated against the coronavirus and is vigilant about cleaning the house every day with disinfectants. The patient has multiple family members who are healthcare providers and also take care of the patient. ED vitals: Blood pressure on arrival was 153/67, SPO2 90% on room air, heart rate 81. Patient did test positive for the coronavirus. Her last dose of the vaccine was in May 2021. Labs were remarkable for hemoglobin of 15.7, AST 79, creatinine kinase 1826, urinalysis 20 ketones, 2+ blood, greater than 20 RBCs, 11-20 WBCs, greater than 50 squamous cells, 2+ bacteria. CXR: No acute cardiopulmonary disease/process or significant change from prior given patient rotation. CT head: No acute intracranial process, re-demonstration of remote injuries involving the right parietal, frontal parietal regions.  Bilateral mastoid effusions with associated opacification of the middle ear, nonspecific white matter changes likely related to chronic ischemic small vessel disease
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Urine ketone body present, Walking aid user, White blood cells urine positive
Clinical narrative: 1/8/2022- Chief Complaint: Lethargy- Source of Information: Available medical record. History of Present Illness:  This is a 69 y.o. female with PMH of being a conjoined twin, developmental delay, GERD, hyperlipidemia, hypertension, seizure disorder, and hypothyroidism presents to the emergency department chief complaint of lethargy and altered mental status. The patient has none nonverbal at baseline with occasional "yes "or "no". History is provided by the patient's first cousin who was the patient's guardian. Guardian states that the patient has had poor p.o. intake over the last 6 days. She states that typically the patient is able to ambulate on her own with a walker but has not done so over the past 6 days. She states that she is fully vaccinated against the coronavirus and is vigilant about cleaning the house every day with disinfectants. The patient has multiple family members who are healthcare providers and also take care of the patient. ED vitals: Blood pressure on arrival was 153/67, SPO2 90% on room air, heart rate 81. Patient did test positive for the coronavirus. Her last dose of the vaccine was in May 2021. Labs were remarkable for hemoglobin of 15.7, AST 79, creatinine kinase 1826, urinalysis 20 ketones, 2+ blood, greater than 20 RBCs, 11-20 WBCs, greater than 50 squamous cells, 2+ bacteria. CXR: No acute cardiopulmonary disease/process or significant change from prior given patient rotation. CT head: No acute intracranial process, re-demonstration of remote injuries involving the right parietal, frontal parietal regions.  Bilateral mastoid effusions with associated opacification of the middle ear, nonspecific white matter changes likely related to chronic ischemic small vessel disease
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Axillary pain, Computerised tomogram abdomen, Computerised tomogram pelvis, Computerised tomogram thorax, Lymphadenopathy
Clinical narrative: Waxing and waning axillary lymphadenopathy and axillary pain possible breast mass right breast
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ultrasound scan
Clinical narrative: Waxing and waning axillary lymphadenopathy and axillary pain possible breast mass right breast
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Blood test, Hypoaesthesia, Nasopharyngitis, Pain in extremity
Clinical narrative: I STARTED FEELING LIKE A BAD COLD WAS COMING ON, I HAD LEFT ARM PAIN AND THEN IT WENT NUMB. I WAS HAVING HEART PALPATATIONS, I FELT WEAK & SO I WENT TO ER.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations, X-ray
Clinical narrative: I STARTED FEELING LIKE A BAD COLD WAS COMING ON, I HAD LEFT ARM PAIN AND THEN IT WENT NUMB. I WAS HAVING HEART PALPATATIONS, I FELT WEAK & SO I WENT TO ER.
Age: 88.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: patient hospitalized
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Nausea, Pain
Clinical narrative: Within a few hours after receiving the second dose of Pfizer COVID-19 vaccine, suddenly experienced fever, chills, full body shaking, headache, body aches, nausea, and fatigue. This lasted for 3 days.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test negative, Tremor
Clinical narrative: Within a few hours after receiving the second dose of Pfizer COVID-19 vaccine, suddenly experienced fever, chills, full body shaking, headache, body aches, nausea, and fatigue. This lasted for 3 days.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient presented at a Covid-19 vaccine event at local store this morning requesting a Pfizer booster. She filled out appropriate paperwork and there were no contraindications noted. Only after patient left and I was reviewing paperwork did I notice the dates of her initial doses of 09/01/2021 and 10/31/2021 and I had given her booster dose sooner than 5 months from completing her primary series. She was still at the facility, so I called patient to come back to the room at 0655. She returned at 0840. I explained that she had received the booster too early and while there is no danger to her I encouraged her to stay aware of any adverse reactions. She said she understood and returned to work.
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Urticaria
Clinical narrative: Allergic reaction started  after 15 hours and worsen. hives all over her body, trunk and back. no signs of anaphylaxis.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: unknown
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient's Moderna Booster given at a 4 month interval instead of 5 month interval
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Oropharyngeal pain, SARS-CoV-2 RNA, SARS-CoV-2 test positive, Throat irritation
Clinical narrative: ST, ITCHY THROAT
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient is 12 years old and received the pediatric dose of 0.2 ml.  Patient should have received 0.3 ml of adult dose
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: Unknown
Age: 71.0
Sex: F
Vaccine: FLUA4
Symptoms: Joint range of motion decreased, Pain in extremity
Clinical narrative: PATIENT CALLED ON 02/04/2022 SAYING EVER SINCE SHE GOT THE VACCINE, HER ARM HURTS AND CANNOT LIFT UP ALL THE WAY. SHE SAID WHEN SHE TAKES IBUPROFEN IT HELPS BUT COMES BACK AFTER FEW HOURS.
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: patient hospitalized
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Urticaria chronic
Clinical narrative: Developed Chronic Urticaria approximately 8-11 days after the booster shot. Allergist had recommended taking Zyrtec for 2 months (starting Dec 6th). As of 2/4/2022, I am still symptomatic for chronic urticaria.
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 11 YEAR OLD CHILD WITH DATE OF BIRTH WRITTEN INCORRECTLY ON CONSENT BUT AGE WRITTEN AS "12". CHILD ACCOMPANIED BY INDIVIDUAL PRESENTING AS MOTHER. CHILD WAS UNDERAGED AT TIME OF VACCINE ADMINISTRATION. RECEIVED UNAUTHORIZED DOSE.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: unknown
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Angiogram, Cerebrovascular accident, Computerised tomogram, Magnetic resonance imaging
Clinical narrative: I had a stroke the morning following the Moderna booster
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: General symptom
Clinical narrative: Onset of symptoms 1/2/22
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Bell's palsy, Eyelid disorder, Facial paralysis, Gaze palsy, Inflammation
Clinical narrative: 11 days after taking the vaccine he begin to exhibit Bell's Palsy symptoms. He began to have facial paralysis on the right half of his face he went to see his NP and he was diagnosed with Bell's Palsy. His right eyelid does not close and his eyeball curls upward into the skull. He had swelling of the face, inflammation in jaw and cheek all on the right side.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: 11 days after taking the vaccine he begin to exhibit Bell's Palsy symptoms. He began to have facial paralysis on the right half of his face he went to see his NP and he was diagnosed with Bell's Palsy. His right eyelid does not close and his eyeball curls upward into the skull. He had swelling of the face, inflammation in jaw and cheek all on the right side.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Blood culture negative, COVID-19, Chest X-ray abnormal, Condition aggravated, Confusional state
Clinical narrative: Patient is a 75 y.o. male with PMH of of ESRD on HD that presented with confusion and fever. In the ER, patient had recorded fever and had an episode of hypotension that improved with IV fluid resuscitation. Patient tested positive for COVID but was not hypoxic. Fever likely secondary to covid. Urine and blood cultures negative for growth.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Culture urine negative, Hypervolaemia, Hypotension, Influenza A virus test negative, Influenza B virus test
Clinical narrative: Patient is a 75 y.o. male with PMH of of ESRD on HD that presented with confusion and fever. In the ER, patient had recorded fever and had an episode of hypotension that improved with IV fluid resuscitation. Patient tested positive for COVID but was not hypoxic. Fever likely secondary to covid. Urine and blood cultures negative for growth.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Mental status changes, Pyrexia, Respiratory syncytial virus test negative, SARS-CoV-2 test positive, Sepsis
Clinical narrative: Patient is a 75 y.o. male with PMH of of ESRD on HD that presented with confusion and fever. In the ER, patient had recorded fever and had an episode of hypotension that improved with IV fluid resuscitation. Patient tested positive for COVID but was not hypoxic. Fever likely secondary to covid. Urine and blood cultures negative for growth.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Chest discomfort, Chest pain, Echocardiogram, Electrocardiogram
Clinical narrative: Developed persistent chest pain that radiated on the left side 3 days after administration of injection, which lasted for 12 days. Chest pain would occur multiple times a day and would range from a stabbing pain to chest tightness. Sometimes would feel a random burst of adrenaline (experienced twice) that would cause extreme chest pain radiating on the left side. The pain that I would experience would last anywhere from 5 minutes up to an hour each time.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Anaphylactic reaction, Asthenia, Confusional state, Dizziness, Dyspnoea
Clinical narrative: Systemic: Allergic: Anaphylaxis-Medium, Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Confusion-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Medium, Systemic: Weakness-Medium, Additional Details: PATIENT FAINTED FOLLOWING A COVID SHOT AND WAS GIVEN AN EPIPEN WHILE CALLING 911 FOR ADDITIONAL HELP.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Flushing, Hyperhidrosis, Lethargy, Syncope
Clinical narrative: Systemic: Allergic: Anaphylaxis-Medium, Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Confusion-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Medium, Systemic: Weakness-Medium, Additional Details: PATIENT FAINTED FOLLOWING A COVID SHOT AND WAS GIVEN AN EPIPEN WHILE CALLING 911 FOR ADDITIONAL HELP.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Unresponsive to stimuli
Clinical narrative: Systemic: Allergic: Anaphylaxis-Medium, Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Confusion-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Medium, Systemic: Weakness-Medium, Additional Details: PATIENT FAINTED FOLLOWING A COVID SHOT AND WAS GIVEN AN EPIPEN WHILE CALLING 911 FOR ADDITIONAL HELP.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: patient hospitalized
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Condition aggravated, Electroencephalogram, Seizure
Clinical narrative: The next day, I had a seizers that lasted for about 10 minutes. I do have a history of seizers. It was control for 10 years. I went to my neurologist. They did blood work to check my medicine levels and I also have an EEG schedule.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Nasal congestion, SARS-CoV-2 RNA, Sneezing
Clinical narrative: NASAL CONGESTION, SNEEZING
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, Interchange of vaccine products
Clinical narrative: Covid Vaccine Dose 1- 2/3/2021- Moderna Lot #042L20A. Covid Vaccine Dose 2- 2/24/ 2921- Pfizer Lot # EM9809. Covid Vaccine  Dose 3- 05/10/2021- Janssen Lot # 203A21A. Covid Vaccine Dose 4- 10/08/2021- Pfizer Lot # FF2590 local Pharmacy.
Age: 29.0
Sex: M
Vaccine: FLUC4, FLU4
Symptoms: Angina pectoris, Dizziness, Pallor, Skin discolouration, Yellow skin
Clinical narrative: Pt said his skin went pale/yellow Under eyes were purple Pain around heart  Lightheaded/Dizzy
Age: 29.0
Sex: M
Vaccine: FLUC4, FLU4
Symptoms: Angina pectoris, Dark circles under eyes, Dizziness, Pallor, Yellow skin
Clinical narrative: Pt said his skin went pale/yellow Under eyes were purple Pain around heart  Lightheaded/Dizzy
Age: 1.0
Sex: F
Vaccine: HEPA, MMR, VARCEL
Symptoms: Pyrexia, Rash morbilliform
Clinical narrative: low grade fever for 2 days before mobilliform rash 2 weeks after vaccine
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus
Clinical narrative: Systemic: Allergic: Itch (specify: facial area, extremities)-Mild, Additional Details: Patient felt neck and face turn red.
Age: 5.0
Sex: F
Vaccine: MMRV
Symptoms: Extra dose administered
Clinical narrative: Patient came in to treatment room for 4 year old vaccination update.  I gave patient MMRV, D tap, Polio.  I documented and realized patient had already received 2 varicella vaccinations.   I discussed with pediatrician she stated patient had received an extra dose of varicella and that there was no harm done.  I proceeded to call patient's mother advised patient received an extra dose of varicella.  Mother stated patient was doing  fine and it was ok.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Interchange of vaccine products, No adverse event
Clinical narrative: Pt presented to the vaccination site on 02/02/2022. The client reported that he received a 2nd dose of Moderna COVID vaccine on 02/07/2021 (Client reported no reaction to his 1st dose of Moderna COVID vaccine received on 01/13/2021). Vaccinator  elevated situation to Lead RN. Client reported tinnitus, nausea, vomiting, vertigo and hearing loss starting in September 2021. Patient saw ENT doctor in October 2021 and was diagnosed with Meniere's disease. Patient reported his ENT doctor didn't think Meniere's disease is related to the Moderna COVID vaccine. Patient did not follow up with ENT or PCP for booster approval. Patient reported history of hypertension and takes hydrochlorothiazide. Patient denied allergic reaction with his 1st and 2nd doses of the Moderna COVID vaccine. Lead Nurse elevated to Clinical Project Coordinators requesting to proceed with the booster dose of Pfizer COVID vaccine.  Per medical consult team, approval to proceed with the booster dose of the Pfizer COVID vaccine was obtained. Client received a booster dose of Pfizer COVID vaccine (LOT# FK9896) on 02/02/2022. The client did not report any symptoms during the 30-minute observation period. Lead RN educated client on possible adverse reactions, when to seek medical care and to register with V-Safe. The client left the vaccination site at approximately 1400 with unlabored respirations and steady gait.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Blood test, Computerised tomogram, Herpes zoster, Ultrasound scan
Clinical narrative: I started out with a left back pain that I hadn't experienced before.  I have a history of Kidney stones in the past but have gone quite a while without one.  After the pain literally didn't let up for an entire day I went to urgent care.  I was sure it was probably a stone.  I had urinalysis, blood work, xray, cat scan, and an ultrasound that were all negative.  They felt it could be a kidney/urine infection and sent me home with medication.  I continued to hurt worse without any urinary symptoms so went back again just sure something was missed on a scan.  I explained at this point to a different ARNP than I saw originally and she lifted my shirt to examine the area that I was complaining and found two small bumps that she assumed to be the beginning outbreak of the shingles.  Over the next two days I broke out into a terrible case of the shingles that ended up wrapping around from my spine to my belly button.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Urine analysis, X-ray
Clinical narrative: I started out with a left back pain that I hadn't experienced before.  I have a history of Kidney stones in the past but have gone quite a while without one.  After the pain literally didn't let up for an entire day I went to urgent care.  I was sure it was probably a stone.  I had urinalysis, blood work, xray, cat scan, and an ultrasound that were all negative.  They felt it could be a kidney/urine infection and sent me home with medication.  I continued to hurt worse without any urinary symptoms so went back again just sure something was missed on a scan.  I explained at this point to a different ARNP than I saw originally and she lifted my shirt to examine the area that I was complaining and found two small bumps that she assumed to be the beginning outbreak of the shingles.  Over the next two days I broke out into a terrible case of the shingles that ended up wrapping around from my spine to my belly button.
Age: 43.0
Sex: F
Vaccine: HEP
Symptoms: Wrong product administered
Clinical narrative: vaccine should have been hib
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Deep vein thrombosis, Oedema, Pain in extremity, Ultrasound scan abnormal
Clinical narrative: Left leg DVT. Pain posterior calf/popliteal and pretibial edema onset Feb 2, 2022.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, No adverse event
Clinical narrative: This was an unauthorized 4th dose of the COVID-19 vaccine. No actual adverse events observed.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Delirium, Hyponatraemia, Metabolic encephalopathy, SARS-CoV-2 test positive
Clinical narrative: Patient received Moderna COVID vaccine on 1/16/21, 2/11/21, and 8/26/21. On 2/1/22, patient admitted to our med/surg unit with acute metabolic encephalopathy likely due to COVID and delirium, sepsis, and hyponatremia. As of today (2/4/22), patient is still admitted in the med/surg unit.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Sepsis
Clinical narrative: Patient received Moderna COVID vaccine on 1/16/21, 2/11/21, and 8/26/21. On 2/1/22, patient admitted to our med/surg unit with acute metabolic encephalopathy likely due to COVID and delirium, sepsis, and hyponatremia. As of today (2/4/22), patient is still admitted in the med/surg unit.
Age: 11.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Patient injected with undiluted pediatric Pfizer vaccine 0.2mL. Patient's mom and MD informed. MD suggested mom to monitor patient. If necessary seek medical attention. The mom said for now both kids doing fine.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Limb injury, Paraesthesia
Clinical narrative: Error: Shoulder joint injury (prolonged pain, tingling, etc.).
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Heavy menstrual bleeding, Menstruation irregular, Ultrasound pelvis normal
Clinical narrative: Per my 2nd vaccine, I had bled for 28 days total about 6 months after getting my vaccine. A few months after my booster shot, 02/03/2022 I started bleeding very heavily after having a period 8 days prior. In between 2nd shot and booster I had a pelvic ultrasound that showed no reasoning behind why I was bleeding so much and for such a long duration.
Age: 10.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product preparation issue
Clinical narrative: Vaccine accidentally drawn from an undiluted vial. Patient received 0.2mL of the vaccine without diluent added. No significant side effects reported.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Blood test, Blood urine present, Chromaturia, Fatigue
Clinical narrative: After receiving the vaccine I went home. The next morning I had a fever, aches, tired, and fatigue. Those stayed for 2 days and nothing went down. The 3rd day I was so extremely tired with a fever. Then I had dark urine that was dark brown n color with blood in it. I went to the ER at Medical Center, and I was there all night from 10PM to the next morning. I was diagnosed with hemolytic anemia. I was prescribed prednisone. They asked me to stay longer in the hospital but I refused to. They told me to follow up with a hematologist. I was on prednisone for a whole week. Then I started having all these extra symptoms like joint pain, tired, and fatigue all the time. I also have nerve pain. I was referred to a rheumatologist. He said I had rheumatoid arthritis. I seen a 2nd doctor and he said I might have rheumatoid arthritis. He told me to take hydroxychloroquine. I seen a 3rd doctor and he said most of my symptoms were a sign of lupus. I have nerve pain, neuropathy, headache, extreme fatigue, and tiredness. I have been taking hydroxyzine for past 7 months, but lately the medication has been giving me ringing in my ears like tinnitus. I have stopped taking it. Recently I saw a doctor and he said I could take Mycophenolate, Azathioprine, or Benlysta instead. I never had this before the vaccine. I'm not supposed to have another dose of this vaccine.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Haemolytic anaemia, Headache, Laboratory test, Neuralgia, Neuropathy peripheral
Clinical narrative: After receiving the vaccine I went home. The next morning I had a fever, aches, tired, and fatigue. Those stayed for 2 days and nothing went down. The 3rd day I was so extremely tired with a fever. Then I had dark urine that was dark brown n color with blood in it. I went to the ER at Medical Center, and I was there all night from 10PM to the next morning. I was diagnosed with hemolytic anemia. I was prescribed prednisone. They asked me to stay longer in the hospital but I refused to. They told me to follow up with a hematologist. I was on prednisone for a whole week. Then I started having all these extra symptoms like joint pain, tired, and fatigue all the time. I also have nerve pain. I was referred to a rheumatologist. He said I had rheumatoid arthritis. I seen a 2nd doctor and he said I might have rheumatoid arthritis. He told me to take hydroxychloroquine. I seen a 3rd doctor and he said most of my symptoms were a sign of lupus. I have nerve pain, neuropathy, headache, extreme fatigue, and tiredness. I have been taking hydroxyzine for past 7 months, but lately the medication has been giving me ringing in my ears like tinnitus. I have stopped taking it. Recently I saw a doctor and he said I could take Mycophenolate, Azathioprine, or Benlysta instead. I never had this before the vaccine. I'm not supposed to have another dose of this vaccine.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Rheumatoid arthritis, Systemic lupus erythematosus
Clinical narrative: After receiving the vaccine I went home. The next morning I had a fever, aches, tired, and fatigue. Those stayed for 2 days and nothing went down. The 3rd day I was so extremely tired with a fever. Then I had dark urine that was dark brown n color with blood in it. I went to the ER at Medical Center, and I was there all night from 10PM to the next morning. I was diagnosed with hemolytic anemia. I was prescribed prednisone. They asked me to stay longer in the hospital but I refused to. They told me to follow up with a hematologist. I was on prednisone for a whole week. Then I started having all these extra symptoms like joint pain, tired, and fatigue all the time. I also have nerve pain. I was referred to a rheumatologist. He said I had rheumatoid arthritis. I seen a 2nd doctor and he said I might have rheumatoid arthritis. He told me to take hydroxychloroquine. I seen a 3rd doctor and he said most of my symptoms were a sign of lupus. I have nerve pain, neuropathy, headache, extreme fatigue, and tiredness. I have been taking hydroxyzine for past 7 months, but lately the medication has been giving me ringing in my ears like tinnitus. I have stopped taking it. Recently I saw a doctor and he said I could take Mycophenolate, Azathioprine, or Benlysta instead. I never had this before the vaccine. I'm not supposed to have another dose of this vaccine.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Bradycardia, COVID-19, Condition aggravated, Dyspnoea
Clinical narrative: Patient received Pfizer COVID vaccine on 3/12/21 and 4/9/21. On 1/23/22, patient tested positive for COVID. On 2/2/22, patient admitted to our med/surg unit with symptomatic bradycardia, dyspnea, AKI, and hypertension. Patient was discharged home the next day on 2/3/22.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Hypertension, Inappropriate schedule of product administration, SARS-CoV-2 test positive
Clinical narrative: Patient received Pfizer COVID vaccine on 3/12/21 and 4/9/21. On 1/23/22, patient tested positive for COVID. On 2/2/22, patient admitted to our med/surg unit with symptomatic bradycardia, dyspnea, AKI, and hypertension. Patient was discharged home the next day on 2/3/22.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort
Clinical narrative: Patient experienced chest tightness, dizziness 15 minutes after the shot.  She sat and rested 30 minutes
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient given booster 24 days after dose #2 because year on patient's vaccine card was incorrect (01/11/2021 instead of 01/11/2022).
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Sinus tachycardia
Clinical narrative: Increased symptomatic episodes related to inappropriate sinus tachycardia. Experiencing much more frequent symptoms.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Atrophy, Bell's palsy
Clinical narrative: Bells Palsy and Atrophy
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Aortic valve incompetence, Aortic valve sclerosis, Arteriosclerosis coronary artery, Aspartate aminotransferase increased
Clinical narrative: ADMITTED. Patient is an 89 y.o. male with h/o chronic pulmonary fibrosis, chronic diastolic CHF, chronic A-Fib on Coumadin, stage 3 CKD, gout and morbid obesity, presenting to the local ER on 1/27 with c/o dyspnea.  He was seen by his outpatient pulmonologist earlier in the day, reporting increasing dyspnea, cough and leg swelling over the past 2 days.   Cough is dry and non-productive.  Dyspnea is worsened by exertion and laying flat.  He reports chronic intermittent chest and back ache which has not changed significantly, and no other associated symptoms.  He is prescribed home supplemental oxygen but does not typically need it.  Over the past few days, he has been on the road a lot and has halved his dose of torsemide from 40 mg daily to 20 mg daily to reduce the amount of stops he'd need to take while driving.  He was once on as high a dose as 60 mg daily but this has been weaned by his cardiologist with the  local Clinic.  Plan late last year was for cardioMEMS implantation, though this was ultimately abandoned and not pursued since due to a procedural complications.  Pulmonology note from earlier today suggests plans for repeat HRCT to evaluate extent of pulmonary fibrosis and discussion regarding anti-fibrotics once past this episode of suspected volume overload.  They recommended he be admitted to the hospital for IV diuresis and directed him to the ER for this purpose.   In the ER, he was febrile, normotensive to moderately hypertensive, with normal HR, mild tachypnea and hypoxia to 86% on RA alone.  He was placed on 2L via NC.  Initial labs are notable for elevated proBNP and initial troponin, renal dysfunction, mild AST elevation with otherwise normal LFT?s, normal CBC and lactate, and positive COVID screen.  BCx were collected.  EKG shows rate controlled A-Fib, incomplete RBBB, and non-specific ST-T changes.  CXR showed retrocardiac opacity reflective of either atelectasis or consolidation, superimposed on underlying interstitial lung disease.     He was ordered IV fluids, but given less than one liter.  He was ordered antibiotics, but these were not given.  He will be given an initial dose of IV Lasix and dexamethasone following my conversation with his ER provider.  Admission was requested for workup and management of acute hypoxic respiratory failure.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Atelectasis, Atrial fibrillation, Back pain, Bacterial test negative, Blood culture negative
Clinical narrative: ADMITTED. Patient is an 89 y.o. male with h/o chronic pulmonary fibrosis, chronic diastolic CHF, chronic A-Fib on Coumadin, stage 3 CKD, gout and morbid obesity, presenting to the local ER on 1/27 with c/o dyspnea.  He was seen by his outpatient pulmonologist earlier in the day, reporting increasing dyspnea, cough and leg swelling over the past 2 days.   Cough is dry and non-productive.  Dyspnea is worsened by exertion and laying flat.  He reports chronic intermittent chest and back ache which has not changed significantly, and no other associated symptoms.  He is prescribed home supplemental oxygen but does not typically need it.  Over the past few days, he has been on the road a lot and has halved his dose of torsemide from 40 mg daily to 20 mg daily to reduce the amount of stops he'd need to take while driving.  He was once on as high a dose as 60 mg daily but this has been weaned by his cardiologist with the  local Clinic.  Plan late last year was for cardioMEMS implantation, though this was ultimately abandoned and not pursued since due to a procedural complications.  Pulmonology note from earlier today suggests plans for repeat HRCT to evaluate extent of pulmonary fibrosis and discussion regarding anti-fibrotics once past this episode of suspected volume overload.  They recommended he be admitted to the hospital for IV diuresis and directed him to the ER for this purpose.   In the ER, he was febrile, normotensive to moderately hypertensive, with normal HR, mild tachypnea and hypoxia to 86% on RA alone.  He was placed on 2L via NC.  Initial labs are notable for elevated proBNP and initial troponin, renal dysfunction, mild AST elevation with otherwise normal LFT?s, normal CBC and lactate, and positive COVID screen.  BCx were collected.  EKG shows rate controlled A-Fib, incomplete RBBB, and non-specific ST-T changes.  CXR showed retrocardiac opacity reflective of either atelectasis or consolidation, superimposed on underlying interstitial lung disease.     He was ordered IV fluids, but given less than one liter.  He was ordered antibiotics, but these were not given.  He will be given an initial dose of IV Lasix and dexamethasone following my conversation with his ER provider.  Admission was requested for workup and management of acute hypoxic respiratory failure.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Blood lactic acid normal, Bronchiectasis, Bundle branch block right, COVID-19, COVID-19 pneumonia
Clinical narrative: ADMITTED. Patient is an 89 y.o. male with h/o chronic pulmonary fibrosis, chronic diastolic CHF, chronic A-Fib on Coumadin, stage 3 CKD, gout and morbid obesity, presenting to the local ER on 1/27 with c/o dyspnea.  He was seen by his outpatient pulmonologist earlier in the day, reporting increasing dyspnea, cough and leg swelling over the past 2 days.   Cough is dry and non-productive.  Dyspnea is worsened by exertion and laying flat.  He reports chronic intermittent chest and back ache which has not changed significantly, and no other associated symptoms.  He is prescribed home supplemental oxygen but does not typically need it.  Over the past few days, he has been on the road a lot and has halved his dose of torsemide from 40 mg daily to 20 mg daily to reduce the amount of stops he'd need to take while driving.  He was once on as high a dose as 60 mg daily but this has been weaned by his cardiologist with the  local Clinic.  Plan late last year was for cardioMEMS implantation, though this was ultimately abandoned and not pursued since due to a procedural complications.  Pulmonology note from earlier today suggests plans for repeat HRCT to evaluate extent of pulmonary fibrosis and discussion regarding anti-fibrotics once past this episode of suspected volume overload.  They recommended he be admitted to the hospital for IV diuresis and directed him to the ER for this purpose.   In the ER, he was febrile, normotensive to moderately hypertensive, with normal HR, mild tachypnea and hypoxia to 86% on RA alone.  He was placed on 2L via NC.  Initial labs are notable for elevated proBNP and initial troponin, renal dysfunction, mild AST elevation with otherwise normal LFT?s, normal CBC and lactate, and positive COVID screen.  BCx were collected.  EKG shows rate controlled A-Fib, incomplete RBBB, and non-specific ST-T changes.  CXR showed retrocardiac opacity reflective of either atelectasis or consolidation, superimposed on underlying interstitial lung disease.     He was ordered IV fluids, but given less than one liter.  He was ordered antibiotics, but these were not given.  He will be given an initial dose of IV Lasix and dexamethasone following my conversation with his ER provider.  Admission was requested for workup and management of acute hypoxic respiratory failure.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiomegaly, Chest X-ray abnormal, Chest pain, Cholelithiasis, Computerised tomogram thorax abnormal
Clinical narrative: ADMITTED. Patient is an 89 y.o. male with h/o chronic pulmonary fibrosis, chronic diastolic CHF, chronic A-Fib on Coumadin, stage 3 CKD, gout and morbid obesity, presenting to the local ER on 1/27 with c/o dyspnea.  He was seen by his outpatient pulmonologist earlier in the day, reporting increasing dyspnea, cough and leg swelling over the past 2 days.   Cough is dry and non-productive.  Dyspnea is worsened by exertion and laying flat.  He reports chronic intermittent chest and back ache which has not changed significantly, and no other associated symptoms.  He is prescribed home supplemental oxygen but does not typically need it.  Over the past few days, he has been on the road a lot and has halved his dose of torsemide from 40 mg daily to 20 mg daily to reduce the amount of stops he'd need to take while driving.  He was once on as high a dose as 60 mg daily but this has been weaned by his cardiologist with the  local Clinic.  Plan late last year was for cardioMEMS implantation, though this was ultimately abandoned and not pursued since due to a procedural complications.  Pulmonology note from earlier today suggests plans for repeat HRCT to evaluate extent of pulmonary fibrosis and discussion regarding anti-fibrotics once past this episode of suspected volume overload.  They recommended he be admitted to the hospital for IV diuresis and directed him to the ER for this purpose.   In the ER, he was febrile, normotensive to moderately hypertensive, with normal HR, mild tachypnea and hypoxia to 86% on RA alone.  He was placed on 2L via NC.  Initial labs are notable for elevated proBNP and initial troponin, renal dysfunction, mild AST elevation with otherwise normal LFT?s, normal CBC and lactate, and positive COVID screen.  BCx were collected.  EKG shows rate controlled A-Fib, incomplete RBBB, and non-specific ST-T changes.  CXR showed retrocardiac opacity reflective of either atelectasis or consolidation, superimposed on underlying interstitial lung disease.     He was ordered IV fluids, but given less than one liter.  He was ordered antibiotics, but these were not given.  He will be given an initial dose of IV Lasix and dexamethasone following my conversation with his ER provider.  Admission was requested for workup and management of acute hypoxic respiratory failure.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Cough, Dyspnoea, Dyspnoea exertional, Echocardiogram
Clinical narrative: ADMITTED. Patient is an 89 y.o. male with h/o chronic pulmonary fibrosis, chronic diastolic CHF, chronic A-Fib on Coumadin, stage 3 CKD, gout and morbid obesity, presenting to the local ER on 1/27 with c/o dyspnea.  He was seen by his outpatient pulmonologist earlier in the day, reporting increasing dyspnea, cough and leg swelling over the past 2 days.   Cough is dry and non-productive.  Dyspnea is worsened by exertion and laying flat.  He reports chronic intermittent chest and back ache which has not changed significantly, and no other associated symptoms.  He is prescribed home supplemental oxygen but does not typically need it.  Over the past few days, he has been on the road a lot and has halved his dose of torsemide from 40 mg daily to 20 mg daily to reduce the amount of stops he'd need to take while driving.  He was once on as high a dose as 60 mg daily but this has been weaned by his cardiologist with the  local Clinic.  Plan late last year was for cardioMEMS implantation, though this was ultimately abandoned and not pursued since due to a procedural complications.  Pulmonology note from earlier today suggests plans for repeat HRCT to evaluate extent of pulmonary fibrosis and discussion regarding anti-fibrotics once past this episode of suspected volume overload.  They recommended he be admitted to the hospital for IV diuresis and directed him to the ER for this purpose.   In the ER, he was febrile, normotensive to moderately hypertensive, with normal HR, mild tachypnea and hypoxia to 86% on RA alone.  He was placed on 2L via NC.  Initial labs are notable for elevated proBNP and initial troponin, renal dysfunction, mild AST elevation with otherwise normal LFT?s, normal CBC and lactate, and positive COVID screen.  BCx were collected.  EKG shows rate controlled A-Fib, incomplete RBBB, and non-specific ST-T changes.  CXR showed retrocardiac opacity reflective of either atelectasis or consolidation, superimposed on underlying interstitial lung disease.     He was ordered IV fluids, but given less than one liter.  He was ordered antibiotics, but these were not given.  He will be given an initial dose of IV Lasix and dexamethasone following my conversation with his ER provider.  Admission was requested for workup and management of acute hypoxic respiratory failure.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Echocardiogram abnormal, Ejection fraction normal, Electrocardiogram ST-T change, Electrocardiogram abnormal, Fibrin D dimer increased
Clinical narrative: ADMITTED. Patient is an 89 y.o. male with h/o chronic pulmonary fibrosis, chronic diastolic CHF, chronic A-Fib on Coumadin, stage 3 CKD, gout and morbid obesity, presenting to the local ER on 1/27 with c/o dyspnea.  He was seen by his outpatient pulmonologist earlier in the day, reporting increasing dyspnea, cough and leg swelling over the past 2 days.   Cough is dry and non-productive.  Dyspnea is worsened by exertion and laying flat.  He reports chronic intermittent chest and back ache which has not changed significantly, and no other associated symptoms.  He is prescribed home supplemental oxygen but does not typically need it.  Over the past few days, he has been on the road a lot and has halved his dose of torsemide from 40 mg daily to 20 mg daily to reduce the amount of stops he'd need to take while driving.  He was once on as high a dose as 60 mg daily but this has been weaned by his cardiologist with the  local Clinic.  Plan late last year was for cardioMEMS implantation, though this was ultimately abandoned and not pursued since due to a procedural complications.  Pulmonology note from earlier today suggests plans for repeat HRCT to evaluate extent of pulmonary fibrosis and discussion regarding anti-fibrotics once past this episode of suspected volume overload.  They recommended he be admitted to the hospital for IV diuresis and directed him to the ER for this purpose.   In the ER, he was febrile, normotensive to moderately hypertensive, with normal HR, mild tachypnea and hypoxia to 86% on RA alone.  He was placed on 2L via NC.  Initial labs are notable for elevated proBNP and initial troponin, renal dysfunction, mild AST elevation with otherwise normal LFT?s, normal CBC and lactate, and positive COVID screen.  BCx were collected.  EKG shows rate controlled A-Fib, incomplete RBBB, and non-specific ST-T changes.  CXR showed retrocardiac opacity reflective of either atelectasis or consolidation, superimposed on underlying interstitial lung disease.     He was ordered IV fluids, but given less than one liter.  He was ordered antibiotics, but these were not given.  He will be given an initial dose of IV Lasix and dexamethasone following my conversation with his ER provider.  Admission was requested for workup and management of acute hypoxic respiratory failure.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Full blood count normal, Gram stain positive, Heart rate normal, Hiatus hernia, High-resolution computerised tomogram of lung
Clinical narrative: ADMITTED. Patient is an 89 y.o. male with h/o chronic pulmonary fibrosis, chronic diastolic CHF, chronic A-Fib on Coumadin, stage 3 CKD, gout and morbid obesity, presenting to the local ER on 1/27 with c/o dyspnea.  He was seen by his outpatient pulmonologist earlier in the day, reporting increasing dyspnea, cough and leg swelling over the past 2 days.   Cough is dry and non-productive.  Dyspnea is worsened by exertion and laying flat.  He reports chronic intermittent chest and back ache which has not changed significantly, and no other associated symptoms.  He is prescribed home supplemental oxygen but does not typically need it.  Over the past few days, he has been on the road a lot and has halved his dose of torsemide from 40 mg daily to 20 mg daily to reduce the amount of stops he'd need to take while driving.  He was once on as high a dose as 60 mg daily but this has been weaned by his cardiologist with the  local Clinic.  Plan late last year was for cardioMEMS implantation, though this was ultimately abandoned and not pursued since due to a procedural complications.  Pulmonology note from earlier today suggests plans for repeat HRCT to evaluate extent of pulmonary fibrosis and discussion regarding anti-fibrotics once past this episode of suspected volume overload.  They recommended he be admitted to the hospital for IV diuresis and directed him to the ER for this purpose.   In the ER, he was febrile, normotensive to moderately hypertensive, with normal HR, mild tachypnea and hypoxia to 86% on RA alone.  He was placed on 2L via NC.  Initial labs are notable for elevated proBNP and initial troponin, renal dysfunction, mild AST elevation with otherwise normal LFT?s, normal CBC and lactate, and positive COVID screen.  BCx were collected.  EKG shows rate controlled A-Fib, incomplete RBBB, and non-specific ST-T changes.  CXR showed retrocardiac opacity reflective of either atelectasis or consolidation, superimposed on underlying interstitial lung disease.     He was ordered IV fluids, but given less than one liter.  He was ordered antibiotics, but these were not given.  He will be given an initial dose of IV Lasix and dexamethasone following my conversation with his ER provider.  Admission was requested for workup and management of acute hypoxic respiratory failure.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Hypertension, Hypervolaemia, Hypoxia, Influenza A virus test negative, Influenza B virus test
Clinical narrative: ADMITTED. Patient is an 89 y.o. male with h/o chronic pulmonary fibrosis, chronic diastolic CHF, chronic A-Fib on Coumadin, stage 3 CKD, gout and morbid obesity, presenting to the local ER on 1/27 with c/o dyspnea.  He was seen by his outpatient pulmonologist earlier in the day, reporting increasing dyspnea, cough and leg swelling over the past 2 days.   Cough is dry and non-productive.  Dyspnea is worsened by exertion and laying flat.  He reports chronic intermittent chest and back ache which has not changed significantly, and no other associated symptoms.  He is prescribed home supplemental oxygen but does not typically need it.  Over the past few days, he has been on the road a lot and has halved his dose of torsemide from 40 mg daily to 20 mg daily to reduce the amount of stops he'd need to take while driving.  He was once on as high a dose as 60 mg daily but this has been weaned by his cardiologist with the  local Clinic.  Plan late last year was for cardioMEMS implantation, though this was ultimately abandoned and not pursued since due to a procedural complications.  Pulmonology note from earlier today suggests plans for repeat HRCT to evaluate extent of pulmonary fibrosis and discussion regarding anti-fibrotics once past this episode of suspected volume overload.  They recommended he be admitted to the hospital for IV diuresis and directed him to the ER for this purpose.   In the ER, he was febrile, normotensive to moderately hypertensive, with normal HR, mild tachypnea and hypoxia to 86% on RA alone.  He was placed on 2L via NC.  Initial labs are notable for elevated proBNP and initial troponin, renal dysfunction, mild AST elevation with otherwise normal LFT?s, normal CBC and lactate, and positive COVID screen.  BCx were collected.  EKG shows rate controlled A-Fib, incomplete RBBB, and non-specific ST-T changes.  CXR showed retrocardiac opacity reflective of either atelectasis or consolidation, superimposed on underlying interstitial lung disease.     He was ordered IV fluids, but given less than one liter.  He was ordered antibiotics, but these were not given.  He will be given an initial dose of IV Lasix and dexamethasone following my conversation with his ER provider.  Admission was requested for workup and management of acute hypoxic respiratory failure.